INTELLECTUAL PROPERTY

PATENT-PENDING FILINGS

NexGen Biologix™ is building a focused intellectual property platform around Energy Reallocation Technology™ (ERT™) and its real-world applications.

The company maintains active provisional patent filings and trademark activity covering core concepts, biological integrations, and system-level designs associated with the platform.

The goal is straightforward: protect the distinguishing characteristics of Energy Reallocation Technology™, preserve novel biological and system-level combinations, and support the long-term commercial value of the platform as it expands across agriculture, environmental systems, infrastructure, and other biological applications.

NEXGENDOT™ PROVISIONAL PATENT APPLICATION

NexGenDOT™ is directed toward a dual-objective biological technology for vegetation management and hydrocarbon remediation across infrastructure, industrial, and environmental systems.

This filing supports NexGenDOT™ applications across roadside systems, military installations, airfields, industrial sites, and contaminated soils where vegetation management and environmental performance intersect.

ENERGY REALLOCATION TECHNOLOGY™ PROVISIONAL PATENT APPLICATION

Energy Reallocation Technology™ represents the core framework behind NexGen Biologix™ platform development.

This filing is directed toward integrated biological systems that influence plant and root-zone response under stress through coordinated carbon, microbial, biological, and growth-regulatory signals.

The platform is designed around the coordinated use of:

• biological support

• organic carbon

• microbial activity and signaling

• targeted growth management

• stress-response timing

Together, these elements form the basis of NexGen Biologix™’s system-level approach to biological performance under pressure. 

Energy Reallocation Technology™ is also supported by federal trademark activity.

A UNIFIED IP PLATFORM DESIGNED FOR EXPANSION

Together, these filings establish an intellectual property framework designed to support platform development across:

• agricultural products

• forage and livestock technologies

• vegetation management systems

• wastewater and environmental systems

• international crop platforms

• future ERT™-based innovations

This strategy allows NexGen Biologix™ to develop current and future platforms while protecting the foundational technology concepts behind its work.

PATENT-PENDING APPLICATIONS IN DEVELOPMENT

The following crop- and system-specific designations represent conceptual, developmental, or platform-specific implementations within the broader ERT™ framework. They do not constitute commercial claims, guaranteed outcomes, or final product representations.

NEXGENDOT™

Dual Objective Treatment for vegetation management and hydrocarbon remediation across transportation corridors, military bases, airfields, industrial properties, and other managed land systems.

NEXGENRCE™

Rice Crop Enhancement focused on resilience, nutrient-use consistency, and biological response in rice systems.

NEXGENCCA™

Cocoa Crop Accelerator designed around crop performance, stress response, and productivity challenges in cocoa-growing systems.

NEXGENSGR™

Sugarcane Growth & Resilience technology focused on growth habit, allocation timing, and stress response in sugarcane systems.

NEXGENSBN™

Soybean Performance Enhancement supporting early development, nutrient uptake, stress response, and reproductive timing considerations.

NEXGENCRN™

Corn Productivity Solution focused on nutrient efficiency, root-zone function, and resilience across maize systems.

NEXGENTRF™

Turfgrass Growth Management for golf courses, sports fields, municipal landscapes, and managed turf systems.

NEXGENCRL™

Cereal Crop Line supporting wheat, sorghum, and related grain systems.

NEXGENVEG™

Vegetable Productivity Platform for high-value specialty crops, greenhouse systems, and intensive production environments.

NEXGENFRT™

Fruit Crop Performance Platform for grapes, citrus, berries, and perennial fruit systems.

IMPORTANT NOTICE

Patent-pending status does not imply regulatory approval, commercial availability, or guaranteed performance. Product designations, platform names, and application areas may evolve as NexGen Biologix™ continues development, testing, regulatory review, and commercialization planning.